Quaker Chemical (NYSE: KWR) CFO logs RSU vesting, tax share surrender and new grant

Rhea-AI Filing Summary

Quaker Chemical EVP and CFO Thomas Coler reported routine equity compensation activity involving restricted stock units (RSUs) and related common shares. On March 15, 2026, RSUs and dividend equivalent rights converted into 1,578 shares of common stock, reflecting vesting of prior awards granted under the Long-Term Performance Incentive Plan.

To cover withholding taxes on this vesting, 541 common shares were surrendered back to the company, a non-market, tax-withholding disposition. After these transactions, Coler directly held 1,478 shares of common stock. He also received a new grant of 2,870 time-based RSUs, which will vest in three annual installments beginning March 15, 2027, each RSU representing a contingent right to one share of Quaker Chemical common stock with dividend equivalent rights accruing as dividends are paid.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coler Thomas

(Last) (First) (Middle)

901 E. HECTOR STREET

(Street)

CONSHOHOCKEN PA 19428-2380

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QUAKER CHEMICAL CORP [ KWR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CFO

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/15/2026		M		666	A	(1)	1,107	D
Common Stock	03/15/2026		M		882	A	(1)	1,989	D
Common Stock	03/15/2026		M		30	A	(2)	2,019	D
Common Stock	03/15/2026		F		541(3)	D	$118.45	1,478	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/15/2026		M			666	(4)	(4)	Common Stock	666	$0	667	D
Restricted Stock Units	(1)	03/15/2026		M			882	(5)	(5)	Common Stock	882	$0	1,764	D
Dividend Equivalent Rights	(2)	03/15/2026		M			30	(2)	03/15/2026	Common Stock	30	(2)	0	D
Restricted Stock Units	(6)	03/15/2026		A		2,870		(6)	(6)	Common Stock	2,870	$0	2,870	D

Explanation of Responses:

1. Restricted stock units (RSUs) convert into common stock on a one-for-one basis.

2. Dividend equivalent rights (DERs) accrued on reporting person's RSUs granted on June 15, 2024 and March 15, 2025. The rights accrued when and as dividends were paid on KWR common stock. This Form 4 reports the settlement of DERs in connection with the second installment of the 2024 RSU grant and the first installment of the 2025 RSU grant, each vesting on March 15, 2026. Each DER was the economic equivalent of one share of KWR common stock.

3. Shares surrendered by reporting person to satisfy withholding tax obligations upon the partial vesting of certain restricted stock units previously granted under the Company's Long-Term Performance Incentive Plan.

4. On June 15, 2024, the reporting person was granted 1,999 time-based RSUs, vesting in three annual installments beginning on March 15, 2025.

5. On March 15, 2025, the reporting person was granted 2,646 time-based RSUs, vesting in three annual installments beginning on March 15, 2026.

6. Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.

Remarks:

	Victoria K. Gehris, Attorney-in-Fact for Thomas Coler	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Quaker Chemical (KWR) CFO Thomas Coler report?

Thomas Coler reported RSU vesting that converted into 1,578 shares of common stock, a tax-withholding surrender of 541 shares, and a new grant of 2,870 time-based RSUs under Quaker Chemical’s Long-Term Performance Incentive Plan.

Did the Quaker Chemical (KWR) CFO buy or sell shares on the open market?

The filing shows no open-market purchases or sales. Shares were acquired through RSU and dividend equivalent right settlements and 541 shares were surrendered solely to satisfy tax withholding obligations tied to vesting, not as discretionary market sales.

How many Quaker Chemical (KWR) shares does the CFO hold after these Form 4 transactions?

Following the reported March 15, 2026 transactions, Thomas Coler directly holds 1,478 shares of Quaker Chemical common stock. This figure reflects RSU conversions into shares and the surrender of 541 shares to cover tax withholding obligations on the vesting awards.

What new equity award did Quaker Chemical (KWR) grant its CFO?

Quaker Chemical granted Thomas Coler 2,870 time-based RSUs that vest in three annual installments starting March 15, 2027. Each RSU represents a right to receive one share of common stock, with dividend equivalent rights accruing as dividends are paid.

What are dividend equivalent rights (DERs) in the Quaker Chemical (KWR) CFO’s Form 4?

Dividend equivalent rights accrued on earlier RSU grants from June 15, 2024 and March 15, 2025. Each right was the economic equivalent of one KWR share and was settled in connection with the RSU vesting on March 15, 2026.

Are the Quaker Chemical (KWR) CFO’s reported transactions routine compensation-related events?

Yes. The filing describes RSU vesting, DER settlements, a new RSU grant, and a tax-withholding share surrender. These are standard equity compensation mechanisms under Quaker Chemical’s Long-Term Performance Incentive Plan rather than discretionary open-market trades.